Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is overuse of sumatriptan a problem? A population-based study

D Gaist1, J Hallas, S H Sindrup

  • 1Department of Clinical Pharmacology, IMB, Odense University, Denmark.

European Journal of Clinical Pharmacology
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pneumatic piston hydrostatic bioreactor for cartilage tissue engineering.

Instrumentation science & technology·2023
Same author

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds.

Heart (British Cardiac Society)·2021
Same author

Use of antipsychotics in Denmark 1997-2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses.

Epidemiology and psychiatric sciences·2021
Same author

Diagnosis and prevalence of diabetic polyneuropathy: a cross-sectional study of Danish patients with type 2 diabetes.

European journal of neurology·2020
Same author

Early changes in tests of peripheral nerve function during oxaliplatin treatment and their correlation with chemotherapy-induced polyneuropathy symptoms and signs.

European journal of neurology·2019
Same author

Randomized trial of facilitated subcutaneous immunoglobulin in multifocal motor neuropathy.

European journal of neurology·2019
Same journal

Efficacy and safety of Ensitrelvir in COVID-19 patients: a systematic review and meta-analysis with focus on viral clearance and RNA change.

European journal of clinical pharmacology·2026
Same journal

Comparing National Health Technology Assessment approaches and the new European Joint Clinical Assessment framework: The case of onco-hematological medicines.

European journal of clinical pharmacology·2026
Same journal

The efficacy of letrozole in the medical management of ectopic pregnancy: a systematic review and meta-analysis.

European journal of clinical pharmacology·2026
Same journal

Detection of intravenous drug physicochemical incompatibilities in clinical practice: e-Harvis compared to reference tools.

European journal of clinical pharmacology·2026
Same journal

Efficacy and safety of doravirine/islatravir for the treatment of HIV-1: a systematic review and meta-analysis of randomized controlled trials with GRADE assessment.

European journal of clinical pharmacology·2026
Same journal

Critical analysis of digitalis glycosides: declining use but increasing poison-center exposure cases for digitoxin.

European journal of clinical pharmacology·2026
See all related articles

Sumatriptan overuse was observed in a Danish population, with a small percentage of users consuming a large proportion of the drug. Potential causes include rebound headache or incorrect use for migraine prophylaxis.

Area of Science:

  • Pharmacology
  • Public Health
  • Clinical Pharmacy

Background:

  • Sumatriptan is a widely used medication for acute migraine attacks.
  • Recent concerns regarding sumatriptan misuse prompted this investigation.

Purpose of the Study:

  • To analyze the usage patterns of sumatriptan in a Danish population.
  • To identify potential trends of sumatriptan misuse and overuse.

Main Methods:

  • Prescription data from a 27-month period were analyzed.
  • Users were categorized into high, intermediate, and low consumption groups based on Defined Daily Doses (DDD).
  • Concurrent use of other medications was also examined.

Main Results:

  • 2,878 sumatriptan users were identified; 45% redeemed only one prescription.

Related Experiment Videos

  • Consumption was highly skewed, with the top 1% of users accounting for 20% of total consumption.
  • High consumption users also exhibited increased use of opioids and ergot alkaloids.

    • Conclusions:

    • Sumatriptan overuse is evident, with potential links to rebound headache or improper prophylactic use.
    • Overuse carries significant economic implications and unknown long-term health effects.
    • Further research is needed to understand the full impact of sumatriptan overuse.